Hypertension in Breast Cancer Patients Receiving Bevacizumab
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Brigham and Women's Hospital